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Report summary 20 
• Presentation for investigation and/or treatment of pruritus represented 4.7 per cent, 2.2 per cent 21 
and 0.9 per cent of total dog, cat and rabbit consultations respectively between 1 May 2018 22 
and 30 June 2019. 23 
• Cytology was the most frequently recorded diagnostic test for both dogs (9.5 per cent of 24 
pruritus survey responses) and cats (4.1 per cent). 25 
• The proportion of pruritus consultations which prescribed antibiotics authorised for systemic 26 
administration (including oral and injectable formulations) decreased between April 2014 and 27 
June 2019 by approximately 50 per cent and 33 per cent in dogs and cats, respectively. 28 
• In a new multi-diagnostic laboratory tumour registry curated by SAVSNET, skin tumours 29 
(including cutaneous and subcutaneous origins) were commonly reported, with the most 30 
commonly reported malignant skin tumours being mast cell tumours in dogs (14.6 per cent of 31 
total pathological diagnoses), and squamous cell carcinomas in cats (7.4 per cent). 32 
• In a clinical narrative summary of records of flea infestation between October 2014 and April 33 
2019 a clear autumnal peak in flea infestation frequency was noted in both dogs and cats, 34 
although evidence of flea infestation was observed throughout the year. 35 
 36 
About this report 37 
This report is the ninth in a series by the Small Animal Veterinary Surveillance Network 38 
(SAVSNET). The other reports in the series are available from: http://veterinaryrecord.bmj.com. 39 
As data are collected for longer periods, the estimates of changes in disease burden will become 40 
more refined, allowing more targeted local and perhaps national interventions. Anonymised data 41 
can be accessed for research by contacting the authors. SAVSNET also welcomes feedback on 42 
this report. More information about SAVSNET is available at 43 
http://www.liverpool.ac.uk/savsnet.44 
  
Syndromic surveillance of pruritus 45 
This is the third summary report on pruritus in companion animals collated by the Small Animal 46 
Veterinary Surveillance Network (SAVSNET) (Arsevska and others 2018; Sanchez-Vizcaino 47 
and others 2016). The present report considers electronic health records (EHRs) captured by 48 
the SAVSNET project from 217 voluntary veterinary practices (482 sites) over a 14-month 49 
period from 1 May 2018 to 30 June 2019. A detailed description of the methodology used by 50 
SAVSNET to capture EHRs has been previously provided (Sánchez-Vizcaíno and others 2015; 51 
Sanchez-Vizcaino and others 2017). A total of 1,823,164 consultations were analysed, of which 52 
70.6 per cent were from dogs, 26.2 per cent were from cats, 1.8 per cent were from rabbits, and 53 
the remaining 1.4 per cent were from other species, or where species was not recorded. Animals 54 
mainly presenting for investigation and/or treatment of pruritus according to the attending 55 
veterinary surgeon or nurse comprised 4.7 per cent, 2.2 per cent and 0.9 per cent of total dog, 56 
cat and rabbit consultations respectively. 57 
 58 
Short questionnaires (Sanchez-Vizcaino and others 2016) were completed by the attending 59 
practitioner after 15,045 random pruritus consultations (12,673 canine, 2,184 feline, 13,652 60 
unique animals). Of these dogs, 37.3 per cent were being presented with a new pruritic 61 
condition, whereas 60.5 per cent were presenting with a continuation of a pruritic condition. Of 62 
these cats, 43.8 per cent were being presented with a new pruritic condition, whereas 53.8 per 63 
cent were presenting with a continuation of a pruritic condition. However, duration of clinical 64 
signs of less than one month was the most common survey response for both dogs (50.3 per 65 
cent) and cats (50.2 per cent). As in previous reports, ears were the most commonly affected 66 
anatomical location in dogs, whereas the dorsal body was most commonly affected in cats 67 
(Table 1). Diagnostic testing was planned in 23.5 per cent of canine and 23.6 feline cases, with 68 
cytology being the most common in both dogs (9.5 per cent) and cats (4.1 per cent). These 69 
findings were broadly consistent with SAVSNET’s previous reports (Arsevska and others 2018; 70 
Sanchez-Vizcaino and others 2016). 71 
 72 
Spatial distribution of pruritus 73 
The spatial distribution of the relative risk for pruritus was evaluated in dogs and cats in 74 
England, Scotland and Wales for each season of the surveillance period between 1 May 2018 75 
and 30 June 2019. For consultations with a valid owner postcode the central point (‘centroid’) 76 
of each postcode was used to indicate the approximate residence of each recorded animal. 77 
Hence, these centroids were aggregated into 20km gridded cells, calculating the proportion of 78 
  
total consultations mainly presenting with pruritus. Standard error (SE) for each cell was 79 
calculated to provide a measure of relative confidence in findings due to variable geographic 80 
consultation coverage, with these values being used to formulate septile bi-variate maps, where 81 
the darkest red colours indicate highest proportions of pruritus (greater than 8.7 per cent and 82 
4.2 per cent for dogs and cats respectively) and lowest standard errors (Figure 1). As previously 83 
observed (Arsevska and others 2018; Sanchez-Vizcaino and others 2016), transient regions of 84 
increased pruritus incidence were distributed seemingly randomly throughout the country and 85 
in most seasons. In future, SAVSNET will need to work with others to develop robust statistical 86 
and practical methods to determine whether these transient increases in pruritus prevalence 87 
represent localised infectious disease outbreaks. 88 
 89 
Pruritus pharmacosurveillance 90 
For the first time in these reports we also analysed pharmaceutical prescriptions given during 91 
pruritus consultations recorded between 1 April 2014 and 30 June 2019 in dogs (n = 219,654 92 
pruritus consultations), cats (n = 43,386) and rabbits (n = 1,299). A semi-automated text mining 93 
methodology was utilised to identify the active substance(s) dispensed in each consultation 94 
using the ‘product dispensed’ field of the EHR; these active substances were summarised into 95 
a hierarchical pharmaceutical classification system as previously described (Singleton and 96 
others 2018; Singleton and others 2017). For the purposes of this report, five pharmaceutical 97 
families of particular relevance to pruritic skin disease were analysed, including antibiotics 98 
authorised for systemic (oral or injectable) or topical (ocular, aural, skin) use; anti-99 
inflammatories authorised for systemic or topical use; antimycotics; endectocides or 100 
ectoparasiticides, and euthanasia. 101 
 102 
For dogs, systemic antibiotics were prescribed in 20.8 per cent of pruritus consultations; topical 103 
antibiotics in 31.8 per cent; systemic anti-inflammatories in 37.2 per cent; topical anti-104 
inflammatories in 27.8 per cent; antimycotics in 22.0 per cent, and endectocides or 105 
ectoparasiticides in 10.1 per cent. For cats, systemic antibiotics were prescribed in 23.5 per cent 106 
of pruritus consultations; topical antibiotics in 11.6 per cent; systemic anti-inflammatories in 107 
60.0 per cent; topical anti-inflammatories in 10.7 per cent; antimycotics in 5.6 per cent, and 108 
endectocides or ectoparasiticides in 28.1 per cent. For rabbits, systemic antibiotics were 109 
prescribed in 9.0 per cent of pruritus consultations; topical antibiotics in 13.8 per cent; systemic 110 
anti-inflammatories in 6.6 per cent; topical anti-inflammatories in 9.4 per cent; antimycotics in 111 
5.8 per cent, and endectocides or ectoparasiticides in 59.2 per cent. Dogs were euthanised in 112 
  
0.02 per cent of pruritus consultations, compared to 0.07 per cent of cat and 0.3 per cent of 113 
rabbit pruritus consultations. 114 
 115 
Temporal trends in prescription frequency were also examined in dogs and cats (Figure 2). Over 116 
the five years analysed, an approximately 50 per cent and 33 per cent decrease in the frequency 117 
with which systemic antibiotics were prescribed in dogs and cats respectively was noted in this 118 
population. Evidence of seasonal prescription variation was observed for endectocide / 119 
ectoparasiticide and systemic anti-inflammatory prescription, peaking in the 3rd or 4th quarter 120 
of each year. This trend was particularly apparent for cats, suggesting a relationship between 121 
presumed parasite infestation and inflammatory responses to such infestations, though this 122 
requires verification. Some pharmaceutical families were very closely temporally matched (e.g. 123 
feline topical antibiotic and topical anti-inflammatory prescription), likely reflecting 124 
prescription of multivalent topical products. 125 
 126 
Update on main presenting complaint temporal trends in companion animals 127 
An observed prevalence time series for three key main presenting complaints (pruritus, 128 
gastroenteric and respiratory) from June 2017 to June 2019 is shown in Figure 3, together with 129 
a seasonal trend line (dark grey line). The trend line was calculated using a Bayesian binomial 130 
generalised linear model trained on weekly prevalence between 2014 and 2019, as fully 131 
described previously (Arsevska and others 2018). Extreme prevalence observations describing 132 
weekly prevalence exceeding 99 per cent credible intervals, and moderate prevalence 133 
observations describing weekly prevalence exceeding 95 per cent credible intervals are 134 
displayed in red and orange respectively. 135 
 136 
These results show continued seasonal prevalence fluctuations in both species, particularly 137 
apparent for pruritus in both dogs and cats, and respiratory disease in dogs. In dogs and cats, 138 
there have been a number of instances of extreme increases in 2019, most notably for respiratory 139 
cases: It is currently unknown whether these findings represent a true increase in disease 140 
prevalence, or reflect the changing nature of participation in the SAVSNET project. 141 
 142 
Laboratory data: Histological and cytological reports of skin tumours in companion 143 
animals 144 
A total of 109,930 canine and feline tumour reports, confirmed via histological (63.9 per cent 145 
of tumour reports) and / or cytological (36.1 per cent) examination, were collated into a new 146 
  
pet tumour registry curated by SAVSNET. These data originate from pathology reports 147 
supplied by three participating diagnostic laboratories between April 2018 and June 2019. Of 148 
total tumour reports, 91.5 per cent were of canine origin, and 8.5 per cent of feline origin.  149 
 150 
In dogs, skin tumours (including both cutaneous and / or subcutaneous) accounted for a large 151 
majority (72.7 per cent) of total tumour reports, whereas approximately half of feline tumours 152 
(54.9 per cent) were skin-based. Figure 4 shows the most frequently diagnosed skin tumours in 153 
dogs and cats as a percentage of total tumour reports, revealing the most commonly reported 154 
malignant skin tumours as mast cell tumours in dogs (14.6 per cent of total tumours), and 155 
squamous cell carcinomas in cats (7.4 per cent). In our report feline lipoma reports were almost 156 
double that of an earlier study (Ho and others 2018), warranting further investigation. 157 
 158 
Table 2 shows the proportions of common dog breeds attending veterinary practices, as 159 
recorded by SAVSNET between 2018 and 2019, with the percentage of such breeds affected 160 
by the five most commonly reported skin tumours identified in this newly formed tumour 161 
registry. We found Labrador retrievers to be more frequently associated with a lipoma report 162 
than their relative veterinary practice attendance frequency would suggest; a finding in line with 163 
a previous study (O'Neill and others 2018). We similarly noted that French bulldogs were over-164 
represented in relation to histiocytoma reports. Histiocytomas tend to predominantly affect dogs 165 
less than four years of age (Taylor and others 1969). Considering that 90.7 per cent (n = 9,272 166 
total dogs) of recorded veterinary practice-attending French bulldogs were born from 2015 167 
onwards, we speculate that a relatively younger breed population might be responsible for the 168 
findings observed here. Finally, a preponderance of boxer dogs to suffer from a variety of 169 
tumours is well known in the veterinary profession (Cohen and others 1974; Gruntzig and others 170 
2016), and indeed this is a finding further corroborated in our current report. The new 171 
SAVSNET tumour registry will provide more information related to tumours in companion 172 
animals in upcoming reports. 173 
 174 
Update on fleas of cats and dogs 175 
Despite increased research and development of control products over several decades (Halos 176 
and others 2014), domestic fleas - the most important ectoparasite of dogs and cats worldwide 177 
– continue to torment companion animals and to infest homes. The most recent practice-level 178 
survey in the UK (Abdullah and others 2019) has shown that some 28.1 per cent of cats and 179 
14.4 per cent of dogs are infested in early summer, and predictably that some 90 per cent of 180 
  
recovered fleas - from both cats and dogs – are the cat flea Ctenocephalides felis felis. Other 181 
studies in the past 10 years have confirmed high rates of infestations of 12-47 per cent in some 182 
European countries. Cat flea populations vary considerably from year to year, but with a 183 
consistent tendency to increase from spring to autumn. The flea life cycle is ‘nest-adapted’, 184 
unique in being able to survive low temperatures and situations where their host comes and 185 
goes; not only can the cat flea be found in houses in the colder months of the year, they may 186 
still be present in premises that have been left unoccupied for several months. 187 
 188 
In this report, we have provided a simple summary of clinical narrative mentions of ‘fleas’ or 189 
‘flea dirt’ between 1 October 2014 and 30 April 2019 in Figure 5. A 10-day moving average of 190 
flea mentions per 1,000 canine or feline consultations respectively has been employed, 191 
excluding any days where less than 1,000 total consultations were collected by SAVSNET in 192 
each respective species. It can be seen that flea prevalence has a clear seasonal pattern, that 193 
fleas can be found on dogs or cats in any month of the year, and that fleas are more frequently 194 
recorded in EHRs for cats than dogs. 195 
 196 
Besides direct skin damage caused by frequent blood feeding, fleas can cause a flea allergic 197 
dermatitis (FAD) in susceptible cats and dogs, and also serve as an intermediate host for the 198 
tapeworm Dipylidium caninum. But perhaps less well known is the animal flea’s potential 199 
worldwide to transmit pathogens – for example Yersinia pestis (plague), Rickettsia typhi 200 
(murine typhus), R. felis (flea spotted fever), Bartonella henselae (cat scratch fever), and in 201 
rabbits myxomatosis. In the UK, Abdullah and others (2019) recently demonstrated that 14 per 202 
cent of pet fleas carry at least one pathogen and approximately 11 per cent were positive for 203 
Bartonella spp., which is also of public health concern. 204 
 205 
Clinical signs 206 
The vast majority of pets suffer from irritation and pruritus; they continuously scratch, groom, 207 
lick or vigorously nibble at the coat. Some cats are able to withstand infestation by hundreds of 208 
parasites and only express mild pruritus, whereas others present with allergic dermatitis with 209 
only a few fleas. Other clinical signs are more specific to cats, such as military dermatitis, which 210 
is defined by numerous papules and small scabs on the back and around the neck. Self-inflicted 211 
injuries are also possible and hair loss can be seen on the abdominal area, legs, flanks or tail as 212 
a result. In heavy infestations, animals may be anaemic. 213 
 214 
  
Diagnosis 215 
Definitive diagnosis relies on finding fleas in the coat, focussing on the tail, ventral face and 216 
neck areas in particular. Evidence of flea presence by finding flea faeces however is somewhat 217 
easier than seeing the fleas themselves: ‘flea dirt’ appears as small semi circles of shiny black 218 
grit up to 1 mm in length, and when placed on dampened blotting paper, colour the paper red 219 
due to the blood-rich diet of fleas. A diagnostic suspicion may be helped by questioning the pet 220 
owner: it is not unusual for family members in the affected household to complain about insect 221 
bites, which often appear in a series of marks on the legs and ankles. It should be remembered 222 
that fleas other than cat and dog fleas may cause problems. Those associated with rodents, birds 223 
and hedgehogs may be found on pets and bite people, complicating control programmes. 224 
 225 
Treatment and control 226 
Details on integrated flea control programmes are available elsewhere: 227 
https://www.esccap.org/guidelines. Eradication of fleas from pets and households remains a 228 
challenge but is achievable, over a timescale of several months, if basic rules and treatment 229 
intervals are respected. Briefly, in cases of existing infestations, a combination of 230 
methodologies is often recommended. Alongside application to the environment of a flea 231 
adulticide and concurrent use of an insect growth regulator to break the flea life cycle, regular 232 
mechanical hoovering to remove flea immature environmental stages is needed, especially in 233 
and around areas where animals sleep. Washing affected pet bedding at temperatures greater 234 
than 60⁰C is also recommended. However, every situation requires a full ‘flea risk’ assessment, 235 
a bespoke plan which addresses the threat of re-infestation, by a thorough analysis of the 236 
behavioural life styles and movements of all in contact animals. Control breakdowns do occur, 237 
sometimes linked to disregard of re-treatment intervals following perceived poor outcomes. As 238 
such, time taken by the veterinary professional to explain the enduring nature of the flea life 239 
cycle and in managing client expectations will always be time well invested. 240 
 241 
There is now a plethora of flea adulticides on the animal health market, but two agents in 242 
particular - imidacloprid and fipronil - were perceived as the holy grail when first introduced in 243 
the early 1980s, being formulated as convenient monthly spot-on applications, and replacing to 244 
a large extent the poorly targeted and neurotoxic organophosphates then in widespread use. 245 
Killing fleas as quickly as possible is highly desirable, and the introduction in the past few years 246 
of the potent fast-acting systemic isoxazolines (fluralaner, afoxolaner, sarolaner and lotilaner) 247 
marks the latest advance in integrated control for ectoparasites of dogs and cats. This 248 
  
pharmaceutical class is very effective against fleas, as well as ticks, and trials are showing high 249 
efficacy against a range of other common mange mites and ectoparasites. Although they do not 250 
prevent biting, cat fleas are killed in a matter of hours following a blood meal from a treated 251 
animal. In the case of fluralaner, which is also formulated for topical use, therapeutic levels are 252 
maintained for up to 3 months (thereby reducing owner compliance issues). In addition, an 253 
enduring  potent impact at sub-lethal levels  on flea reproduction has been demonstrated 254 
experimentally (Williams and others 2014), with the high potential therefore to break the natural 255 
flea life cycle in the domestic setting. 256 
 257 
Horizon scanning 258 
Tuberculosis in cats 259 
We recently saw the publication of an outbreak of Mycobacterium bovis in six clinically sick 260 
cats (five of which died or were euthanased) and seven in-contact cats across England. Affected 261 
cats frequently presented with weight loss, lethargy, anorexia, respiratory signs and palpable 262 
abdominal masses / lymphadenopathy: some showed gastrointestinal signs creating the 263 
potential for even greater exposure to owners (O'Halloran and others 2019). Two owners also 264 
had immunological evidence of tuberculosis infection. 265 
 266 
All affected cats lived exclusively indoors. Frequent causes of tuberculosis infection were 267 
excluded including wildlife / rodent contact, raw milk and exposure to known infectious 268 
humans. However, there was strong evidence of an association with a particular commercial 269 
raw pet food. According to its manufacturer (Nature Valley), they no longer manufacture and 270 
sell the particular venison-based product implicated. The Edinburgh research team behind the 271 
research state that new cases are still occurring. Animals known to have been exposed to the 272 
recalled food, or which have been exposed to a confirmed case but are displaying no clinical 273 
signs, should be tested by interferon assay at least four weeks after the last known exposure. 274 
This detailed piece of research highlights the potential for tuberculosis in cats even in areas 275 
where bovine tuberculosis is not endemic. Although risk to in-contact humans is considered 276 
low, people clearly can contract tuberculosis from infected cats (PHE 2014). 277 
 278 
 Myxomatosis 279 
Myxomatosis is caused by a poxvirus transmitted by biting parasites between rabbits. Using 280 
data derived from SAVNSET veterinary practices we have confirmed that August – November 281 
is the peak season for this disease. The disease is best controlled by vaccination. 282 
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Tables 296 
Table 1: Canine (n=12,673) and feline (n=2,184) anatomical sites affected by pruritus in 297 
randomly selected consultations between 1 May 2018 and 30 June 2019.* 298 
Anatomical site Number (%) of dogs Number (%) of cats 
Dorsal body 1,993 (15.7) 894 (40.9) 
Ears 6,300 (49.7) 560 (25.6) 
Face 1,789 (14.1) 670 (30.7) 
Feet / limbs 3,538 (27.9) 339 (15.5) 
Tail-head / perineum 1,782 (14.1) 405 (18.5) 
Ventral body 3,112 (24.6) 611 (28.0) 
Other site 957 (7.6) 209 (9.6) 
* The same animal could present with more than one affected anatomical site per consultation299 
  
Table 2: Comparison of percentage of common dog breeds visiting SAVSNET-participating 300 
veterinary practices, as a proportion of total recorded dog consultations with percentage of 301 
histological / cytological skin tumour reports as collated by SAVSNET from three veterinary 302 
diagnostic laboratories, between April 2018 and June 2019. 303 
*NOS refers to ‘not otherwise specified’ whereby a specific tumour designation was not 304 
provided by the examining pathologist, but instead a general term e.g. carcinoma was used. 305 
Such occurrences most commonly referred to cytological examinations.  306 
Breed 
Veterinary-
visiting breed 
percentage (%) 
Percentage (%) of histological / cytological tumour reports 
Lipoma 
Mast cell 
tumour 
Histiocytoma 
Soft tissue 
sarcoma 
Neoplasia 
(NOS*) 
Labrador Retriever 8.4 18.4 16.1 7.1 9.0 14.6 
Crossbreed 21.2 17.2 12.0 14.3 19.2 14.6 
Cocker Spaniel 5.2 6.6 0.9 5.7 2.9 4.4 
Staffordshire Bull Terrier 3.6 5.1 17.4 5.7 7.6 6.6 
English Springer Spaniel 3.1 4.4 1.6 2.6 4.1 3.8 
Boxer 0.9 0.8 7.4 4.4 3.6 3.1 
Pug 1.2 0.1 4.8 2.4 0.1 1.1 
French Bulldog 1.7 0.04 1.1 5.7 0.1 0.9 
Jack Russell Terrier 5.1 3.2 3.6 2.6 4.3 3.0 
307 
  
Figures 308 
 309 
Figure 1: Septile bi-variate maps indicating proportion of total canine and feline consultations 310 
(1 May 2018 – 30 Jun 2019) presenting mainly for investigation and/or treatment of pruritus, 311 
summarised by 20km gridded cells encompassing England, Scotland and Wales. Proportion has 312 
been modelled against standard error to provide a measure of relative confidence in findings 313 
according to the volume of data collected in each cell. Darker red colours indicate areas of 314 
relatively high confidence and prevalence. 315 
  316 
  
 317 
Figure 2: Percentage of canine and feline pruritus consultations where systemic antibiotics; 318 
topical antibiotics; systemic anti-inflammatories; topical anti-inflammatories; endectocides / 319 
ectoparasiticides, or antimycotics were prescribed, by quarter (Q2 2014 – Q2 2019). Shaded 320 
regions refer to 95% confidence intervals, calculated to adjust for clustering within veterinary 321 
practice site (bootstrapped estimated, n replicates = 5,000). 322 
  323 
  
 324 
Figure 3: Observed prevalence per 1,000 consultations for pruritus, gastroenteritis and 325 
respiratory disease in cats and dogs attending SAVSNET-participating practices from June 326 
2017 to June 2019. Red points represent the extreme outliers (outside the 99 per cent credible 327 
interval [CI]), orange points represent the moderate outliers (outside the 95 per cent CI but 328 
within the 99 per cent CI), and green points represent the average trend (within the 95 per 329 
cent CI). 330 
  331 
  
 332 
 333 
Figure 4: Most frequently reported skin tumours in dogs and cats, as a percentage of total 334 
tumour reports in each species.*NOS refers to ‘not otherwise specified’ whereby a specific 335 
tumour designation was not indicated by the examining pathologist, but instead a general 336 
term e.g. carcinoma was used; such occurrences most frequent in cytological examinations. 337 
  338 
  
 339 
Figure 5:  Flea infestation records per 1,000 dog and cat consultations expressed as a 10-day 340 
rolling average, as recorded within the free text clinical narrative as collected by SAVSNET 341 
between October 2014 and April 2019.  Days collecting less than 1,000 total consultations 342 
were excluded from the analyses.343 
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